Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk NeuroblastomaVeronica Veschi, Carol J. Thiele, Ty C. Voss et al.|Cancer Cell|2017Cited by 128